We are taking a pro-active approach to healthcare, with Scotland’s first immediately accessible screening service for liver health

About Us

LiverScan aims to identify individuals with potential liver disease and fatty livers using the gold standard examination with a FibroScan device. Every day in the UK, more than 40 people die from liver disease and 25% of the adult population are currently estimated to have non-alcoholic fatty liver disease (NAFLD). Our aim is to be one step ahead and encourage people to take control of their liver health.

The company was formed by a group of friends with medical, health and business angel backgrounds. One of the group came across the FibroScan device following his own MRI examination which was not targeting the liver, but which indicated a potential fatty liver. That diagnosis lead to an examination using the FibroScan device, carried out by a hepatologist. Without that MRI scan identifying an issue, and because most liver disease is asymptomatic, the fatty liver issue would not have been identified, addressed or resolved.

The examination using the FibroScan device, a non-invasive ultrasound procedure, produces 2 results: liver fat (CAP) and liver stiffness (LSM) scores. Fatty liver disease can lead to liver inflammation, scarring and eventually liver cirrhosis or liver cancer. Whilst alcohol can be the cause, in the UK, roughly half of liver disease is classified as NAFLD. It is hugely important that liver disease is caught early, and with simple changes in lifestyle, the damage can often be reversed, partly because of the regenerative nature of the organ itself.

Our group of shareholders all quickly bought into the importance of liver health and the benefits that could result from introducing examinations using the FibroScan device within Scotland on a self-referral basis.

We have also established an advisory board to review our clinical operations, who provide valuable expertise and guidance to optimise our service and ensure patient-centric excellence.

Read our Latest News

LiverScan Group Team

The Team

Ian

Ian Gray

Founder & Non-Executive Director
B. Com (Hons) CA


Walter

Professor Walter Nimmo

Non-Executive Chairman


Bruce

Bruce Anderson,

Chief Executive Officer & Executive Director
BA, ACMA & FCIOBS


Chris

Chris Ross

Non-Executive Director
BVM&S, MRCVS


Accreditations

LiverScan takes great pride in its approach to managing and conducting its operations. We are deeply committed to upholding the utmost standards in quality and customer engagement, IT security, health and safety, and environmental sustainability. You can download a copy of our certificates below.

Latest News

LiverScan Launches New Promotional Video Following Collaboration with Dangerous Studio

LiverScan is pleased to share the launch of its new promotional…
Chrtismas present image
Liver Cancer Awareness Month Ribbon
HDL and LDL cholesterol
World Hepatitis Day 2025
MyLife365 App sdisplayed on phone screen

MyLife365 App Launches in Edinburgh

We’re excited to bring you MyLife365, the free lifestyle app…
SME UK Enterprise Award logo for Best Liver Screening Clinic 2025

LiverScan Wins Two SME UK Enterprise Awards

We are proud to announce that LiverScan has…
Edinburgh Chamber of Commerce and LiverScan Logos

LiverScan Joins Edinburgh Chamber of Commerce

LiverScan is delighted to announce that we are now a proud member…

Collaborations

British Liver Trust

The British Liver Trust provides information and support on all types of liver disease.

British Liver Trust

Dr Laura Wyness

Award winning Registered Nutritionist specialising in menopausal and evidence-based nutrition communication.

Scottish Life Sciences Association

The voice of Scotland’s Lifesciences industries

Echosens

A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®

FibroScan